Genes differentially expressed in the peripheral zone compared to the transitional zone of the normal human prostate and their potential regulation by ETS factors

Molecular Medicine Reports

Volumn 5, Issue 1, 2012, Pages 32-36

  Adler, David ^a   Lindstrot, Andreas ^a   Ellinger, Jor̈g ^a   Rogenhofer, Sebastian ^a   Buettner, Reinhard ^a   Wernert, Nicolas ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

ETS factors; Glands; Prostate; Stroma

Indexed keywords

ASPORIN; BLOOD CLOTTING FACTOR 7; FIBROCYSTIN; K RAS PROTEIN; MICROFIBRILLAR ASSOCIATED PROTEIN 5; NEURONAL NITRIC OXIDE SYNTHASE; PROSTATE PROTEIN; REGENERATING ISLET DERIVED 1ALPHA PROTEIN; REGENERATING ISLET DERIVED 1BETA PROTEIN; TRANSCRIPTION FACTOR ETS; TRANSCRIPTION FACTOR RUNX1; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; GENE EXPRESSION; GENETIC REGULATION; HUMAN; HUMAN TISSUE; MALE; METASTASIS; NUCLEOTIDE SEQUENCE; PROMOTER REGION; PROSTATE; PROSTATE CANCER; PROSTATE PERIPHERAL ZONE; PROSTATE TRANSITIONAL ZONE; UPREGULATION;

EID: 84855224475     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2011.628     Document Type: Article

References (45)

1. Kumar-Sinha C, Tomlins SA and Chinnaiyan AM: Recurrent gene fusions in prostate cancer. Nat Rev 8: 497-511, 2008.
2. Richardson AM, Woodson K, Wang Y, et al.: Global expression analysis of prostate cancer-associated stroma and epithelia. Diagn Mol Pathol 16: 189-197, 2007. (Pubitemid 350196975)
3. Arora R, Koch MO, Eble JN, Ulbright TM, Li L and Cheng L: Heterogeneity of Gleason grade in multifocal adenocarcinoma of the prostate. Cancer 100: 2362-2366, 2004. (Pubitemid 38657883)
4. Ruijter ET, van de Kaa CA, Schalken JA, Debruyne FM and Ruiter DJ: Histological grade heterogeneity in multifocal prostate cancer. Biological and clinical implications. J Pathol 180: 295-299, 1996. (Pubitemid 26393679)
5. DeMarzo AM, Nelson WG, Isaacs WB and Epstein JI: Pathological and molecular aspects of prostate cancer. Lancet 361: 955-964, 2003. (Pubitemid 36332115)
6. McNeal JE: The zonal anatomy of the prostate. Prostate 2: 35-49, 1981.
7. Joshua AM, Evans A, van der Kwast T, et al.: Prostatic preneoplasia and beyond. Biochim Biophys Acta 1785: 156-181, 2008.
8. McNeal JE, Redwine EA, Freiha FS and Stamey TA: Zonal distribution of prostatic adenocarcinoma. Correlation with histologic pattern and direction of spread. Am J Surg Pathol 12: 897-906, 1988. (Pubitemid 19011040)
9. Guo CC, Zuo G, Cao D, Troncoso P and Czerniak BA: Prostate cancer of transition zone origin lacks TMPRSS2-ERG gene fusion. Mod Pathol 22: 866-871, 2009.
10. Colombo P, Patriarca C, Alfano RM, et al.: Molecular disorders in transitional vs. peripheral zone prostate adenocarcinoma. Int J Cancer 94: 383-389, 2001. (Pubitemid 32906069)
11. Laczko I, Hudson DL, Freeman A, Feneley MR and Masters JR: Comparison of the zones of the human prostate with the seminal vesicle: morphology, immunohistochemistry, and cell kinetics. Prostate 62: 260-266, 2005. (Pubitemid 40129064)
12. He J, Pan Y, Hu J, Albarracin C, Wu Y and Dai JL: Profile of Ets gene expression in human breast carcinoma. Cancer Biol Ther 6: 76-82, 2007. (Pubitemid 46294180)
13. Tomlins SA, Rhodes DR, Perner S, et al.: Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science 310: 644-648, 2005. (Pubitemid 41528150)
14. Furusato B, Tan SH, Young D, et al.: ERG oncoprotein expression in prostate cancer: clonal progression of ERG-positive tumor cells and potential for ERG-based stratification. Prostate Cancer Prostatic Dis 13: 228-237, 2010.
15. Kohn EC: Invasion and metastasis: biology and clinical potential. Pharmacol Ther 52: 235-244, 1991.
16. Duffy MJ, McGowan PM and Gallagher WM: Cancer invasion and metastasis: changing views. J Pathol 214: 283-293, 2008. (Pubitemid 351212383)
17. Oikawa T: ETS transcription factors: possible targets for cancer therapy. Cancer Sci 95: 626-633, 2004.
18. Hashiya N, Jo N, Aoki M, et al.: In vivo evidence of angiogenesis induced by transcription factor Ets-1: Ets-1 is located upstream of angiogenesis cascade. Circulation 109: 3035-3041, 2004. (Pubitemid 38811459)
19. Rothhammer T, Hahne JC, Florin A, et al.: The Ets-1 transcription factor is involved in the development and invasion of malignant melanoma. Cell Mol Life Sci 61: 118-128, 2004. (Pubitemid 38121905)
20. Hahne JC, Okuducu AF, Kaminski A, Florin A, Soncin F and Wernert N: Ets-1 expression promotes epithelial cell transformation by inducing migration, invasion and anchorage-independent growth. Oncogene 24: 5384-5388, 2005. (Pubitemid 43080108)
21. Van der Heul-Nieuwenhuijsen L, Hendriksen PJ, van der Kwast TH and Jenster G: Gene expression profiling of the human prostate zones. BJU Int 98: 886-897, 2006. (Pubitemid 44368045)
22. Wellmann A, Wollscheid V, Lu H, et al.: Analysis of microdissected prostate tissue with ProteinChip arrays - a way to new insights into carcinogenesis and to diagnostic tools. Int J Mol Med 9: 341-347, 2002.
23. Okuducu AF, Janzen V, Hahne JC, Ko Y and Wernert N: Influence of histochemical stains on quantitative gene expression analysis after laser-assisted microdissection. Int J Mol Med 11: 449-453, 2003.
24. Okuducu AF, Hahne JC, von Deimling A and Wernert N: Laser-assisted microdissection, techniques and applications in pathology (Review). Int J Mol Med 15: 763-769, 2005.
25. Akiyama Y: TFSEARCH: Searching Transcription Factor Binding Sites, 2011. Available from URL: http://mbs.cbrc.jp/research/db/TFSEARCHJ.html.
26. Heinemeyer T, Wingender E, Reuter I, et al.: Databases on transcriptional regulation: TRANSFAC, TRRD and COMPEL. Nucleic Acids Res 26: 362-367, 1998. (Pubitemid 28295292)
27. Laboratory CSH: Transcriptional Regulatory Element Database, 2011.
28. Sasaki Y, Minamiya Y, Takahashi N, et al.: REG1A expression is an independent factor predictive of poor prognosis in patients with breast cancer. Ann Surg Oncol 15: 3244-3251, 2008.
29. Astrosini C, Roeefzaad C, Dai YY, Dieckgraefe BK, Jons T and Kemmner W: REG1A expression is a prognostic marker in colorectal cancer and associated with peritoneal carcinomatosis. Int J Cancer 123: 409-413, 2008. (Pubitemid 351842027)
30. Zhou L, Zhang R, Wang L, et al.: Upregulation of REG Ialpha accelerates tumor progression in pancreatic cancer with diabetes. Int J Cancer 127: 1795-1803, 2010.
31. Lee KE and Bar-Sagi D: Oncogenic KRas suppresses inflammation-associated senescence of pancreatic ductal cells. Cancer Cell 18: 448-458, 2010.
32. Milagre C, Dhomen N, Geyer FC, et al.: A mouse model of melanoma driven by oncogenic KRAS. Cancer Res 70: 5549-5557, 2010.
33. Rechreche H, Montalto G, Mallo GV, et al.: pap, reg Ialpha and reg Ibeta mRNAs are concomitantly up-regulated during human colorectal carcinogenesis. Int J Cancer 81: 688-694, 1999. (Pubitemid 29214374)
34. Tang JQ, Fan Q, Wan YL, et al.: [Ectopic expression and clinical significance of tissue factor/coagulation factor VII complex in colorectal cancer]. Beijing Da Xue Xue Bao. 41: 531-536, 2009 (In Chinese).
35. Yokota N, Koizume S, Miyagi E, et al.: Self-production of tissue factor-coagulation factor VII complex by ovarian cancer cells. Br J Cancer 101: 2023-2029, 2009.
36. Dorn L, Menezes LF, Mikuz G, Otto HF, Onuchic LF and Sergi C: Immunohistochemical detection of polyductin and co-localization with liver progenitor cell markers during normal and abnormal development of the intrahepatic biliary system and in adult hepatobiliary carcinomas. J Cell Mol Med 13: 1279-1290, 2009.
37. Fowler M, Borazanci E, McGhee L, et al.: RUNX1 (AML-1) and RUNX2 (AML-3) cooperate with prostate-derived Ets factor to activate transcription from the PSA upstream regulatory region. J Cell Biochem 97: 1-17, 2006. (Pubitemid 43050176)
38. Reid-Lombardo KM, Fridley BL, Cunningham JM, Sarr M and Petersen GM: Inflammation-related gene variants as risk factors for pancreatic cancer. Cancer Epidemiol Biomarkers Prev 20: 1251-1254, 2011.
39. Spivey KA and Banyard J: A prognostic gene signature in advanced ovarian cancer reveals a microfibril-associated protein (MAGP2) as a promoter of tumor cell survival and angiogenesis. Cell Adh Migr 4: 169-171, 2010.
40. Turashvili G, Bouchal J, Baumforth K, et al.: Novel markers for differentiation of lobular and ductal invasive breast carcinomas by laser microdissection and microarray analysis. BMC Cancer 7: 55, 2007.
41. Behrens P, Rothe M, Wellmann A, Krischler J and Wernert N: The Ets-1 transcription factor is up-regulated together with MMP 1 and MMP 9 in the stroma of pre-invasive breast cancer. J Pathol 194: 43-50, 2001.
42. Behrens P, Mathiak M, Mangold E, et al.: Stromal expression of invasion-promoting, matrix-degrading proteases MMP-1 and -9 and the Ets 1 transcription factor in HNPCC carcinomas and sporadic colorectal cancers. Int J Cancer 107: 183-188, 2003. (Pubitemid 37152895)
43. Wernert N, Stanjek A, Kiriakidis S, et al.: Inhibition of angiogenesis in vivo by Ets-1 antisense oligonucleotides-inhibition of Ets-1 transcription factor expression by the antibiotic fumagillin. Angewandte Chemie 38: 3228-3231, 1999. (Pubitemid 29533905)
44. Wernert N, Gilles F, Fafeur V, et al.: Stromal expression of c-Ets1 transcription factor correlates with tumor invasion. Cancer Res 54: 5683-5688, 1994. (Pubitemid 24346267)
45. Alipov G, Nakayama T, Ito M, et al.: Overexpression of Ets-1 proto-oncogene in latent and clinical prostatic carcinomas. Histopathology 46: 202-208, 2005. (Pubitemid 40293019)